Loading...
Loading...
Analysts at Bank of America initiated coverage on
Aduro BioTech IncADRO with a Buy rating. The target price for Aduro Biotech is set to $40. Aduro Biotech shares closed at $30.85 on Friday.
Analysts at Evercore Partners initiated coverage on
Virtu Financial IncVIRT with a Buy rating. The target price for Virtu Financial is set to $25. Virtu Financial shares closed at $22.30 on Friday.
Analysts at Oppenheimer initiated coverage on
Godaddy IncGDDY with a Outperform rating. The target price for Godaddy is set to $31. Godaddy shares closed at $24.88 on Friday.
RBC Capital initiated coverage on
KemPharm IncKMPH with a Outperform rating. The target price for KemPharm is set to $18. KemPharm shares closed at $12.05 on Friday.
Analysts at Deutsche Bank initiated coverage on
Wix.Com LtdWIX with a Hold rating. The target price for Wix.com is set to $25. Wix.com shares closed at $23.75 on Friday.
Deutsche Bank initiated coverage on
Endurance International Group Hldgs IncEIGI with a Hold rating. The target price for Endurance International Group is set to $19. Endurance International Group shares closed at $20.96 on Friday.
Analysts at Guggenheim Securities initiated coverage on
Loading...
Loading...
with a Buy rating. The target price for Paratek Pharmaceuticals is set to $37. Paratek Pharmaceuticals' shares closed at $26.56 on Friday.
RBC Capital initiates coverage on
Godaddy IncGDDY with a Outperform rating. The target price for Godaddy is set to $30. Godaddy shares closed at $24.88 on Friday.
Analysts at Guggenheim Securities initiated coverage on
Egalet CorpEGLT with a Buy rating. The target price for Egalet is set to $24. Egalet shares closed at $9.10 on Friday.
Wedbush initiated coverage on
Cidara Therapeutics IncCDTX with a Outperform rating. The target price for Cidara Therapeutics is set to $22. Cidara Therapeutics shares closed at $14.94 on Friday.
Loading...
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in